Cardinal Health, Inc.
NYSECardinal Health enters the week after earnings with the Street uniformly bullish, a fresh $5 billion buyback authorization in hand — and nearly every C-suite executive heading for the exit at the same time. The insider story is the sharpest tension in this note. On August 14, CEO Jason Hollar sold 103,449 shares at $235.17, pocketing roughly $24.3 million in a single transaction. He…
CAH cost to borrow doubles to 0.48% in one week, highest level since late July, as shares available to borrow tighten despite minimal short interest at 2.9% of float.
Cardinal Health enters the week after earnings with the Street uniformly bullish, a fresh $5 billion buyback authorization in hand — and nearly every C-suite executive heading for the exit at the same time. The insider…
Cardinal Health announced a $5 billion equity buyback authorization on August 11, 2026. This is a repurchase program — it authorizes the company to buy back its own shares over time. No shares have necessarily been…
Snapshot as of 20 Sept 2026
Cardinal Health reported fiscal year-end results on August 11, and the Street's response has been immediate and nearly unanimous — six firms lifted price targets on the same day, the clearest post-earnings signal of…
Cardinal Health reports fiscal year-end results today against a backdrop of unusually uniform analyst conviction — and a stock that has moved meaningfully since the last preview was filed. The analyst setup remains the…
Cardinal Health reports its fiscal fourth-quarter results on August 11 with one of the clearest bullish consensus builds seen across healthcare distributors this earnings season. The analyst story is the standout…
Cardinal Health heads into the first full week of May under pressure, having shed 4.2% over the past week to close at $197, while the Street digests a mixed earnings signal and a wave of freshly cut price targets. The…
Cardinal Health reports its Q3 2026 results today against an uncomfortable backdrop: the stock is down nearly 7% over the past month, trading at $192.88, and the mean analyst price target of $247 implies roughly 28%…
Cardinal Health reports Q3 fiscal 2026 results this morning — and for once, the pre-print setup tilts notably in the bulls' favour. The most telling move arrived Tuesday, when William Blair initiated coverage with an…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CAH — free to start on ORTEX.
Sign up for free →Open CAH on ORTEX